Book Value per Share: NanoViricides Inc. (NNVC)

Graphic logo of NanoViricides (NNVC)

Drivers for the validation of the nanomedicine platform of NanoViricides, Inc. (NNVC) are currently crystallizing, while R&D costs are already priced in. Flexibility is ensured through the outsourcing of production and testing, which eliminates massive capital expenditures. The book value per common share reflects asset dynamics, with the latest value recorded as 0.38. Transparent management with deep expertise in virology supports the stability of the share price.

NanoViricides Corp (NNVC): Share Book Value from 07/04/2022 to 10/27/2026

NanoViricides Inc. - analytical breakdowns and key metrics (NNVC)

- price and consensus price forecast:
Stock Quotes NanoViricides Corp|NNVC - Price Target Chart
- market capitalization data:
Market Capitalization NanoViricides, Inc.|NNVC - Real Price to Acquire Entire Company
- book capitalization data:
Net Assets per Single Share NanoViricides|NNVC - Net Asset Value|Market Capitalization to Book Value Ratio nanoviricides.com|NNVC - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital NanoViricides, Inc.|NNVC - Long-Term Debt to Capital|Short-Term Debt to Equity NanoViricides Corp|NNVC - Aggregate Debt Obligations|Debt to Book Capitalization Ratio NanoViricides, Inc.
Fundamental company valuation:nanoviricides.com - NNVC
Manufactured products of NanoViricides Corp

Book value per share determines the volume of net assets attributable to a single security, reflecting the actual asset backing of investments and the efficiency of equity capitalization. Since NanoViricides, Inc. (NNVC) focuses exclusively on internal R&D without utilizing M&A, the book value per share trend verifies the organic growth of intellectual property value, confirming the company's fundamental stability.

Competitors of NanoViricides, Inc. (NNVC)

GILD - Accounting Value per Share|CDTX - Net Assets per Single Share|NVAX (Novavax, Inc.) - Book Value per Share|CVAC (curevac.com) - Accounting Value per Share|Net Assets per Single Share Valneva VALN|Share Book Value Vir Biotechnology Inc|SIGA Corp (SIGA) - Book Value per Share|Accounting Value of a Share Emergent Bio (EBS)|Book Value per Share AVIR (Atea Pharmaceuticals)|Invivyd Inc - Book Value per Share|Net Assets per Single Share Enanta Pharmaceuticals, Inc. (ENTA)|INO: Accounting Value of a Share|HLVX (HilleVax Corp) - Net Assets per Single Share|Kalaris Tx (KLRS) - Accounting Value per Share|DYAI (Dyadic International Inc) - Book Value per Share|Book Value per Share talphera.com (TLPH)|Cocrystal Pharma (COCP) - Accounting Value per Share|Accounting Value of a Share trawspharma.com TRAW|Accounting Value per Share Dogwood Therapeutics DWTX|Net Assets per Single Share Qualigen Corp QLGN|Book Value per Share ALVR (AlloVir Bio)|VBIV: Net Assets per Share|Net Assets per Single Share virios.com VIRI|Accounting Value of a Share Vaxart